EXCEMED, in collaboration with the European Charcot Foundation (ECF) and AcademicCME, is planning a Virtual Course to be held prior to ECTRIMS-ACTRIMS Congress.

This live, Online Programme will take place from 8am to 11.30am (EST), on both 9th & 10th September, 2020. International experts will address the main scientific breakthroughs in the field and will provide practical suggestions for managing patients in clinical practice.

As the ACTRIMS-ECTRIMS Congress is going Virtual, we are converting the course into a Distance Learning Interactive Programme.

Even more in these circumstances, EXCEMED wants to keep its tradition of high value education and strongly believes that keeping in touch with experts and learners is the basis of ongoing growth and innovation.

The Foundation aims to keep its tradition of Pre-ECTRIMS Educational activities and, even more so, in 2020. Thanks to the partnership with the ECF and Academic CME, plans to offer remote attendees a deeper and more comprehensive learning experience in this field, has been made possible.

This is intended to be a multi-sponsor educational project, supported by a number of companies active in the neurodegenerative diseases/MS field.

Increasing knowledge on the pathogenesis of Multiple Sclerosis (MS) has led to the development of new treatment strategies and novel prognostic biomarkers. Progressive MS, which has always been considered an ‘orphan’ disease, is starting to be treated with disease modifying therapies; neuroprotective and remyelinating strategies are under investigation with the aim of promoting and preserving neuronal health. New measures suitable to establish the true effectiveness of these new therapeutic approaches are required and are currently tested in clinical trials. This course aims to provide updated scientific insights on the world of contemporary MS.